Vor Biopharma named Sandy Mahatme as chief financial officer and chief business officer, effective July 9. Mahatme, 60, joins the clinical-stage biotechnology company with more than 30 years of ...

CAMBRIDGE, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of ...

Nvidia CEO Jensen Huang may soon surpass Warren Buffett in terms of net worth, as his company is the first to ever reach a ...

Nvidia (NASDAQ: NVDA) is the first company in history to hit a market cap of $4 trillion. The increase took the net worth of ...

Pine Labs CEO Amrish Rau may net ₹1,000 crore as firm files for IPO Pine Labs' DRHP shows CEO Amrish Rau's net worth may cross ₹1,000 crore as he sells shares via OFS, alongside Peak XV, PayPal, ...

While estimates of her net worth vary, the figures reportedly fall between $35 million and $50 million as of 2025. Let’s delve deeper into how Wintour built her fortune: sources of income ...

Anna Wintour net worth: What was Vogue diva worth before stepping down as editor-in-chief While her era as editor-in-chief comes to a close, she will continue her influence at Condé Nast as ...

Tandem Bank has today announced that Neil Chandler has been named CEO, subject to regulatory approvals. His appointment signals the next chapter for the award-winning fintech and underlines its ...

Mowgli founder Nisha Katona has promoted her chief operating officer Lucy Worth to chief executive. The move marks the first time Katona, a former barrister who founded the Indian street food group ...

Anna Wintour reveals how to dress for it! Anna Wintour's Net Worth and Salary Anna Wintour’s net worth is estimated at $50 million as of latest estimates, Celebrity Networth notes.

Anna Wintour has stepped down as editor-in-chief for US Vogue after nearly four decades. She shared the news with Vogue staff on Thursday, June 26, 2025.

SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) ('Calidi”), a clinical-stage biotechnology company pioneering the development of systemic oncolytic ...